Pilot Study of Enhanced Vital Sign Monitoring After Major Abdominal and Vascular Surgery Comparing In-Hospital and At-Home Monitoring to Standard Care

What this Trial Is About

Researchers are evaluating the feasibility of an enhanced vital sign monitoring solution for adults undergoing major abdominal or vascular surgery. This study compares enhanced monitoring of vital signs both in the hospital and at home to the standard care, aiming to see if this can increase the number of days patients are alive and at home within 30 days after surgery. The study also addresses the challenge that current vital sign monitoring after surgery may miss important changes in a patients condition, especially once patients leave the hospital. Participants in the intervention group will receive additional continuous vital sign monitoring in the hospital from 8am to 5pm starting the day of surgery until 3 days after surgery or discharge, using a Philips monitor that tracks heart rate, oxygen saturation, and blood pressure. After discharge, they will use a Cloud DX Inc. home monitoring kit twice daily for 3 days. The control group will receive standard monitoring in the hospital and usual follow-up after discharge. Both groups will complete questionnaires 14 and 30 days after surgery, and a follow-up phone call will be conducted at 30 days. Participants will be closely monitored through questionnaires and vital sign measurements during hospitalization and at home. Researchers will assess outcomes such as days alive at home within 30 days after surgery, quality of recovery, major morbidity, mortality, emergency visits, readmissions, and length of hospital stay. The study also includes protocols for clinical escalation if vital signs exceed alert thresholds. The total participation involves in-hospital monitoring followed by home monitoring and follow-up assessments up to 30 days postoperatively.

Enhanced Vitals Monitoring After Major Surgery Trial